| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |